This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Hokusan Co. Ltd, National Institute of Advanced Industrial Science and Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020
Title: Takashi Aoki: Innovator in Therapeutic Solutions
Introduction
Takashi Aoki is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of chronic intractable external otitis. His innovative approach has led to the development of a unique therapeutic agent that showcases immediate and sustained effects.
Latest Patents
Aoki holds a patent for his invention titled "Therapeutic effect of oral interferon a administration on chronic intractable external otitis." The objective of this invention is to provide a therapeutic agent that effectively treats chronic intractable external otitis. The composition includes interferon-α (IFNα) as an active ingredient, which can be administered orally. This method has been shown to inhibit, alleviate, treat, and prevent the condition, even when administered in very small amounts. Aoki's patent represents a significant advancement in therapeutic options for patients suffering from this ailment.
Career Highlights
Throughout his career, Takashi Aoki has worked with esteemed organizations such as the National Institute of Advanced Industrial Science and Technology and Hokusan Co. Ltd. His experience in these institutions has allowed him to refine his research and contribute to the development of innovative medical solutions.
Collaborations
Aoki has collaborated with notable colleagues, including Akira Ito and Takeshi Matsumura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Takashi Aoki's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving therapeutic options for chronic conditions. His work continues to inspire future research and development in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile